Corpus ID: 28506612

The common wart: intralesional treatment with bleomycin sulfate.

@article{Cordero1980TheCW,
  title={The common wart: intralesional treatment with bleomycin sulfate.},
  author={A. Cordero and H. A. Guglielmi and A. Woscoff},
  journal={Cutis},
  year={1980},
  volume={26 3},
  pages={
          319-20, 322, 324
        }
}
  • A. Cordero, H. A. Guglielmi, A. Woscoff
  • Published 1980
  • Medicine
  • Cutis
  • Thirty-six patients were treated for single or multiple warts by intralesional injection of bleomycin sulfate (Blenoxane) at the base of the wart. The dose varied according to the size of the lesion and ranged from 0.2 to 0.8 mg per injection, up to a maximum total dose of 2 mg. The cure rates were as follows: 67 percent in plantar warts; 82 percent in ungual warts; and 80 percent in warts located elsewhere. The cure rate for all patients was 75 percent. The drug was well tolerated and the… CONTINUE READING
    28 Citations

    Topics from this paper

    Intralesional bleomycin sulfate injection for the treatment of verruca plantaris.
    • 14
    Therapeutic evaluation for intralesional injection of bleomycin sulfate in 143 resistant warts.
    • 50
    Intralesional Bleomycin for Warts
    • 7
    Bleomycin in the treatment of recalcitrant warts.
    • 99
    Lymphangitis as a complication of intralesional bleomycin therapy.
    • 7